CVS Caremark Price Target Raised to $90.00 at Susquehanna (CVS)
Investment analysts at Susquehanna boosted their price target on shares of CVS Caremark (NYSE:CVS) from $85.00 to $90.00 in a note issued to investors on Friday. The firm currently has a “positive” rating on the stock. Susquehanna’s price objective indicates a potential upside of 14.47% from the stock’s previous close.
Shares of CVS Caremark (NYSE:CVS) opened at 78.62 on Friday. CVS Caremark has a one year low of $55.66 and a one year high of $78.86. The stock has a 50-day moving average of $75.65 and a 200-day moving average of $71.56. The company has a market cap of $92.221 billion and a P/E ratio of 19.90.
CVS Caremark (NYSE:CVS) last issued its quarterly earnings data on Friday, May 2nd. The company reported $1.02 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.05 by $0.03. The company had revenue of $32.70 billion for the quarter, compared to the consensus estimate of $32.31 billion. During the same quarter last year, the company posted $0.22 earnings per share. CVS Caremark’s revenue was up 6.3% compared to the same quarter last year. Analysts expect that CVS Caremark will post $4.46 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on CVS. Analysts at Zacks reiterated a “neutral” rating on shares of CVS Caremark in a research note on Thursday, May 29th. They now have a $81.00 price target on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of CVS Caremark from $80.00 to $83.00 in a research note on Wednesday, May 28th. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of CVS Caremark in a research note on Wednesday, May 28th. They now have a $80.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $77.21.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.